The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening
文献类型:期刊论文
作者 | Ye, Xiaoqing1; Zhang, Rukang2; Lian, Fulin2; Zhang, Weiyao1; Lu, Wenchao2; Han, Jie2; Zhang, Naixia2![]() ![]() ![]() |
刊名 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
![]() |
出版日期 | 2019-02-15 |
卷号 | 29期号:4页码:638-645 |
关键词 | WDR5-MLL1 interaction Leukemia Small-molecule High-throughput screening Fluorescence polarization (FP) |
ISSN号 | 0960-894X |
DOI | 10.1016/j.bmcl.2018.12.035 |
通讯作者 | Ye, Fei(yefei@zstu.edu.cn) ; Ding, Hong(hding@simm.ac.cn) |
英文摘要 | The protein-protein interaction between WDR5 (WD40 repeat protein 5) and MLL1 (mixed-lineage leukemia 1) is important for maintaining optimal H3K4 methyltransferase activity of MLL1. Dysregulation of MLL1 catalytic function is relevant to mixed-lineage leukemia, and targeting WDR5-MLL1 interaction could be a promising therapeutic strategy for leukemia harboring MLL1 fusion proteins. To date, several peptidomimetic and non-peptidomimetic small-molecule inhibitors targeting WDR5-MLL1 interaction have been reported, yet the discovery walk of new drugs inhibiting MLL1 methytransferase activity is still in its infancy. It's urgent to find other small-molecule WDR5-MLL1 inhibitors with novel scaffolds. In this study, through fluorescence polarization (FP)-based high throughput screening, several small-molecule inhibitors with potent inhibitory activities in vitro against WDR5-MLL1 interaction were discovered. Nuclear Magnetic Resonance (NMR) assays were carried out to confirm the direct binding between hit compounds and WDR5. Subsequent similarity-based analog searching of the 4 hits led to several inhibitors with better activity, among them, DC_M5_2 displayed highest inhibitory activity with IC50 values of 9.63 +/- 1.46 mu M. Furthermore, a molecular docking study was performed and disclosed the binding modes and interaction mechanisms between two most potent inhibitors and WDR5. |
WOS关键词 | H3K4 METHYLTRANSFERASE ACTIVITY ; LEUKEMIA MLL PROTEIN ; HIGH-AFFINITY ; WDR5 ; OPTIMIZATION ; DISRUPTION ; MECHANISMS |
资助项目 | Ministry of Science and Technology of China (National Key R&D Program of China)[2017YFB0202600] ; Natural Science Foundation of Zhejiang Province[LY18H300008] ; National Natural Science Foundation of China[21472208] ; National Natural Science Foundation of China[81625022] ; National Natural Science Foundation of China[81803339] ; Chinese Academy of Science[XDA12020353] ; K. C. Wong Education Foundation |
WOS研究方向 | Pharmacology & Pharmacy ; Chemistry |
语种 | 英语 |
WOS记录号 | WOS:000457262100023 |
出版者 | PERGAMON-ELSEVIER SCIENCE LTD |
源URL | [http://119.78.100.183/handle/2S10ELR8/290533] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Ye, Fei; Ding, Hong |
作者单位 | 1.Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Drug Discovery & Design Ctr,State Key Lab Drug Re, Shanghai 201203, Peoples R China 3.China Pharmaceut Univ, Dept Med Chem, Nanjing 211198, Jiangsu, Peoples R China 4.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China 5.Pilot Natl Lab Marine Sci & Technol Qingdao, Open Studio Druggabil Res Marine Nat Prod, 1 Wenhai Rd, Qingdao 266237, Peoples R China |
推荐引用方式 GB/T 7714 | Ye, Xiaoqing,Zhang, Rukang,Lian, Fulin,et al. The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2019,29(4):638-645. |
APA | Ye, Xiaoqing.,Zhang, Rukang.,Lian, Fulin.,Zhang, Weiyao.,Lu, Wenchao.,...&Ding, Hong.(2019).The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,29(4),638-645. |
MLA | Ye, Xiaoqing,et al."The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 29.4(2019):638-645. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。